Analyst Insight: In 2015, I predicted that the healthcare industry was finally sharpening its focus on profitability and efficiency. While I was writing this Walgreens moved on Rite-Aid and further consolidated the retail pharmacy market, but more importantly strengthened their negotiating leverage on price breaks. If the cost of the supply chain from sourcing to production to distribution was not a priority, it just became critical to profit margins and customer service. - Brian Hudock, Partner, Tompkins International
Analyst Insight: Global, web, mobile, catalogs and trunk shows are only a few of the channels by which we sell and buy today. Retailers are investing billions of dollars to upgrade their tech infrastructure as well as their fulfillment processes to respond to customers as well as threatening and clever competitors’ moves. But omnichannel is not just for retailers. - Ann Grackin, CEO, ChainLink Research
Analyst Insight: Labor costs are rising just as the availability of workers is shrinking and turnover is increasing. According to the Census Bureau, 60 million Baby Boomers will exit the workforce by 2025, but only 40 million new workers will enter. Companies must rethink how they bridge that gap and keep costs in-line. Many life sciences companies are reaching a scale where investments in automation help replace manual, labor-intensive operations. But companies must be careful in evaluating automation investments. - Roger Counihan, Life Sciences Industry Leader, Fortna Inc.
Analyst Insight: Over the next few years, numerous new regulations are coming into effect worldwide, requiring pharmaceutical manufacturers, distributors, dispensers and others up and down the chain to build serialization, verification, and traceability into their supply chains. While there is tremendous potential ROI and added value from these investments, right now all the focus is on the race to comply before the deadlines hit. Those who get there first will likely have a head start in finding additional value from these newfound capabilities. - Bill McBeath, Chief Research Officer, ChainLink Research
In the latest Worldwide Commercial Robotics Spending Guide, International Data Corp. forecasts global spending on robotics and related services to grow at a compound annual growth rate of 17 percent from more than $71bn in 2015 to $135.4bn in 2019. The guide measures purchases of robotic systems, system hardware, software, robotics-related services, and after-market robotics hardware on a regional level across 13 key industries and 52 use cases.
Analyst Insight: Logistics accounts for the bulk of humanitarian relief expenditures. Application of technologies and frameworks used in commercial supply chain activities can reduce costs, increase velocity and save lives during crisis. - Kathy Fulton, Executive Director, American Logistics Aid Network
Sixty percent of supply chain managers say their organization is too focused on internal, tactical concerns to be able to collaborate effectively with external partners, at a time when globalization is forcing companies to view and use their supply chain more effectively.
As pharmaceutical companies have expanded target markets and outsourced production over the last decade, the supply chain has become increasingly global, virtual and vulnerable. As a result, counterfeit activity is thriving - and patients have suffered and died from counterfeit and contaminated drugs.
The latest supply-chain news, analysis, trends and tools for executives in the pharmaceutical and biotech industries. Learn how pharmaceutical and biotech companies and their suppliers around the world are managing the flow of products across all channels of the enterprise. Experts sound off on forecasting and demand planning, supply-chain visibility, logistics outsourcing, inventory optimization, transportation management, warehouse management, supply-chain security, corporate social responsibility and more.
Subscribe to our Daily Newsletter!
Timely, incisive articles delivered directly to your inbox.